Live Breaking News & Updates on தகுதி தொற்று நோய் ப்ராடக்ட் பதவி

Stay updated with breaking news from தகுதி தொற்று நோய் ப்ராடக்ட் பதவி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Peptilogics Strengthens Leadership Team with Five Key Strategic Hires

Peptilogics Strengthens Leadership Team with Five Key Strategic Hires
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Steve Kulp , Nik Bhide , Prnewswire Peptilogics , Nikhil Nik Bhide , Jodie Giilon , Marc Lesnick , Albert Fonticiella , Jodie Gillon , Jonathan Steckbeck , Peter Thiel , Corporate Services , University Of California , Service Strategy At Viropharma , Georgetown University School Of Foreign Service , Health Economics , Georgetown University , George Washington University , University Of Rochester , Juniata College , Idera Pharmaceuticals , San Diego School Of Medicine , Founders Fund , Merck Research Laboratories , Hebrew University ,

Peptilogics Strengthens Leadership Team with Three Strategic Appointments

Peptilogics Strengthens Leadership Team with Three Strategic Appointments
- Dr. David Huang, leader in anti-infective drug development, to serve as SVP, Chief Medical Officer
- Dr. Nick Nystrom, global leader in life sciences AI, to serve as SVP, Computing & Data
- Nicholas Pachuda, seasoned expert in business strategy, to serve as SVP, Portfolio Strategy & Development
News provided by
Share this article
Share this article
PITTSBURGH, March 17, 2021 /PRNewswire/ Peptilogics, a biotechnology platform company leveraging computational design to discover novel peptide therapeutics, announces the appointments of Dr. David Huang as SVP, CMO, Nick Nystrom as SVP, Computing & Data, and Nicholas Pachuda as SVP, Portfolio Strategy & Development. These leaders bring decades of experience in anti-infective drug development, orthopedic infection, computing and solutions architecture, and portfolio management. They join Peptilogics leadership team to help drive i ....

Nick Nystrom , Carnegie Mellon , Jonathan Steckbeck , Nicholas Pachuda , Depuy Synthes , David Huang , Peter Thiel , Founders Fund , X Biotix Pharmaceuticals , Contrafect Corp , Portfolio Strategy Development , School Of Public Health , Pittsburgh Supercomputing Center , University Of Texas At School Medicine , Pennsylvania College Of Podiatric Medicine , University Of Pittsburgh , Department Of Veterans Affairs , Portfolio Strategy , Chief Scientist , Pittsburgh Supercomputing , Worldwide Vice President , External Innovation , Enabling Technologies , Orthopedic Franchise , Small Bone , Podiatric Medicine ,

Peptilogics Strengthens Leadership Team with Three Strategic Appointments

Peptilogics Strengthens Leadership Team with Three Strategic Appointments
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Nick Nystrom , Prnewswire Peptilogics , Carnegie Mellon , Nicholas Pachuda , Jonathan Steckbeck , Depuy Synthes , David Huang , Peter Thiel , Founders Fund , X Biotix Pharmaceuticals , Contrafect Corp , Portfolio Strategy Development , School Of Public Health , Pittsburgh Supercomputing Center , University Of Texas At School Medicine , Pennsylvania College Of Podiatric Medicine , University Of Pittsburgh , Department Of Veterans Affairs , Portfolio Strategy , Chief Scientist , Pittsburgh Supercomputing , Worldwide Vice President , External Innovation , Enabling Technologies , Orthopedic Franchise , Small Bone ,

Peptilogics Raises $35.4M in Series B Financing

Peptilogics, a Pittsburgh, PA-based clinical-stage biotechnology company, closed a $35.4m Series B financing.
The round was led by Presight Capital, with participation from a new investor syndicate including Founders Fund as well as from existing investor Peter Thiel.
The company intends to use the funds to expand its computational platform and invest in technologies to improve its drug design engine, as well as accelerate development of a pipeline of peptide therapeutics including the lead clinical asset, PLG0206, which has demonstrated first-in-class safety and best-in-class efficacy.
Led by Jonathan Steckbeck, PhD, MBA, Founder and CEO, Peptilogics combines proven drug development expertise with proprietary artificial intelligence (AI) and machine learning methods to find connections among diverse biomedical data from across the entire drug development spectrum to map a new universe of peptide sequences. The company’s platform then generates novel, optimized ....

Jonathan Steckbeck , Peter Thiel , Founders Fund , Presight Capital , Drug Designation , Qualified Infectious Disease Product Designation , ஜொனாதன் சிடேக்க்பெக்க் , பீட்டர் திீஏல் , நிறுவனர்கள் நிதி , மருந்து பதவி , தகுதி தொற்று நோய் ப்ராடக்ட் பதவி ,